Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 6 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiotherapy 4 Radiation 3 trametinib 2 dabrafenib 2 Radiotherapy, Intensity-Modulated 2 Bevacizumab 2 vorasidenib 1 veliparib 1 trastuzumab deruxtecan 1 ribociclib 1 Spinal Puncture 1 Protons 1 Proton Therapy 1 Pluvicto 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Flucytosine 1 Everolimus 1 Carboplatin 1 CTLA-4 Antigen 1 AZD1390 1 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × vorasidenib × 30 days × Clear all

NCT06809322 2026-05-22

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡